Trial NCT04150562

View at ClinicalTrials.gov 
Org. Study IDs: 200007
Secondary IDs: 20-C-0007

Last trial update was posted on 2022-05-17

MeSH Interventions

Avelumab

MeSH Conditions

Carcinoma Carcinoma, Renal Cell Kidney Neoplasms

Other Conditions

Clear-Cell Renal Carcinoma

Stopping Reasons

This study was terminated early due to manufacturer withdrawal of support (study medication) due to lack of enrollment.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID